Basic Information
Basic information for LINC02018-217-31aa-2
Peptide Name LINC02018-217-31aa-2
Genome Position chr3:75457076-75457168[+]
Species Human
Peptide Sequence MESRQWAKRKRKLRNQPGAVAHACDLGTLGS
Peptide Length 31
Unique No (LINC02018-201-31aa-2,LINC02018-207-31aa-2,LINC02018-212-31aa-2,LINC02018-232-31aa-2,LINC02018-233-31aa-2)
Grand Average of Hydropathicity -0.9419
Relative Molecular Mass 4006.47
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000272690;LINC02018
Transcript ID/Name ENST00000658657;LINC02018-217
Transcript Length 1710
Coding Ability 0.4281
DNA Sequence Corresponding to Peptide ATGGAATCCAGGCAATGGGCAAAGAGAAAAAGAAAACTAAGGAATCAGCCAGGTGCAGTGGCTCATGCTTGTGATCTTGGCACTTTGGGAAGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :